Authors: Peter Campbell
Editor, Jade Parker recently spoke with Peter Campbell, Head of Cancer Genetics and Genomics at the Wellcome Trust Sanger Institute (Cambridge, UK) and joint head of the Cancer Genome Project.
Peter’s research focuses on the use of next-generation sequencing technologies for annotating cancer genomes. He is co-investigator on a Cancer Research UK (CRUK) funded Grand Challenge project which aims to identify the preventable causes of cancer.
In this interview you can find out about:
• Work the Cancer Genome Project is conducting
• The CRUK funded Grand Challenge project: an international search to identify the preventable causes of cancer
• How mapping the process of early tumor development could help earlier detection and prevention
• Peter Campbell’s thoughts on the how the field of cancer genomics will progress
00.25 What sparked your interest in Cancer Genomics?
01.11 You are the joint head of the Cancer Genome Project. Could you tell us about the work you and your team are currently conducting?
03:01 You are co-investigator on the Grand Challenge project focused on identifying preventable causes of cancer. Could you tell us about the aims of this project?
05: 37 The project is an international collaboration. What advantages are there to to conducting this project on an international level?
07:05 How could mapping the process of early tumor development help us to detect and prevent cancer at an earlier stage?
08:48 Where do you think the field will be in the next 5 years?
To see all the videos in this series of interviews with cancer genomics opinion leaders, subscribe to our Youtube channel